HPC Matters Plenary to Focus on Precision Medicine
High performance computing's impact on the future of precision medicine will be the focus of the HPC Matters Plenary Session
at SC16, to be held Monday, November 14, 5:45-6:45 p.m. Leading voices from the frontlines of clinical care, medical research, HPC system evolution, pharmaceutical R&D and public policy will share diverse perspectives on the future of precision medicine, HPC’s role in driving it and how it will impact society.
The panel will be moderated by Steve Conway, vice president of HPC research at IDC. The invited panelists are:
- Dr. Mitchell Cohen, Director of Surgery, Denver Health Medical Center; Professor, University of Colorado School of Medicine.
- Dr. Martha Head, Senior Director, The Noldor; Acting Head, Insights from Data at GlaxoSmithKline Pharmaceuticals
- Dr. Dimitri Kusnezov, Chief Scientist & Senior Advisor to the Secretary, U.S. Department of Energy, National Nuclear Security Administration
- Dr. Steve Scott, Chief Technology Officer, Cray Inc.